CoreCap Advisors LLC Purchases 37,949 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

CoreCap Advisors LLC increased its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 344,990.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,960 shares of the company's stock after purchasing an additional 37,949 shares during the period. CoreCap Advisors LLC's holdings in Ryan Specialty were worth $2,436,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Mariner LLC grew its holdings in Ryan Specialty by 3.4% during the 4th quarter. Mariner LLC now owns 5,278 shares of the company's stock valued at $339,000 after buying an additional 172 shares in the last quarter. Sanctuary Advisors LLC boosted its stake in shares of Ryan Specialty by 1.2% during the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock worth $1,045,000 after purchasing an additional 188 shares during the period. State of Alaska Department of Revenue grew its stake in shares of Ryan Specialty by 1.6% during the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company's stock valued at $778,000 after buying an additional 190 shares during the last quarter. CIBC Asset Management Inc boosted its holdings in Ryan Specialty by 5.6% during the 4th quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock valued at $236,000 after acquiring an additional 196 shares during the period. Finally, Treasurer of the State of North Carolina increased its stake in Ryan Specialty by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 44,990 shares of the company's stock worth $2,887,000 after purchasing an additional 280 shares during the period. 84.82% of the stock is owned by institutional investors.

Ryan Specialty Price Performance

Ryan Specialty stock opened at $70.92 on Thursday. The stock has a market capitalization of $18.58 billion, a P/E ratio of 102.79, a P/E/G ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a 12-month low of $52.02 and a 12-month high of $77.16. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The firm's 50-day moving average is $70.15 and its two-hundred day moving average is $68.72.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, hitting analysts' consensus estimates of $0.39. The company had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. Ryan Specialty's revenue was up 25.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.35 earnings per share. Equities analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's dividend payout ratio is currently 141.18%.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 11.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. TD Cowen started coverage on Ryan Specialty in a research note on Thursday, April 10th. They issued a "buy" rating and a $89.00 price objective on the stock. Wells Fargo & Company dropped their price target on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. UBS Group lifted their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. Barclays lowered their price objective on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research note on Friday, April 11th. Finally, Royal Bank of Canada cut their target price on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. One analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, Ryan Specialty currently has an average rating of "Moderate Buy" and an average target price of $75.67.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.